Ambros Leadership Team to Run Combined Company After Werewolf Merger

Companies: Werewolf Therapeutics · Ambros Therapeutics · Event Type: Leadership Succession · Incoming CEO: Joseph “Jay” Hagan · Date: August 21, 2026 Summary As part of the all-stock merger between Werewolf Therapeutics and Ambros Therapeutics, Ambros CEO Joseph “Jay” Hagan will become CEO of the…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
Samsung Biologics Moves Into Peptide Manufacturing
Boulevard Bio Launches with $65 Million
GSK – $1B SiranBio Oligo Deal